...in Disease Activity of Subcutaneous (SC) Epcoritamab in...
ClinicalTrials数据库提供临床试验A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma的登记号NCT0